Cited by 205Diabetes Management and ResearchDiabetes and associated disordersDiabetes Treatment and Management

Hypoglycemia in Type 1 Diabetes Mellitus

Open access
Cryer, Philip E.·2010·Endocrinology and Metabolism Clinics of North America

Abstract

Iatrogenic hypoglycemia, typically the result of the interplay of therapeutic hyperinsulinemia and compromised defenses resulting in hypoglycemia-associated autonomic failure (HAAF) in diabetes, is a problem for people with type 1 diabetes mellitus (T1DM). It causes recurrent morbidity is sometimes fatal, leads to recurrent hypoglycemia, and precludes euglycemia over a lifetime of T1DM. Risk factors include those that result in relative or absolute insulin excess and those indicative of HAAF in diabetes. Elimination of hypoglycemia from the lives of people with T1DM will likely be accomplished by new treatment methods that provide plasma glucose-regulated insulin replacement or secretion.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ecl.2010.05.003

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • People with type 1 diabetes, particularly those with concomitant chronic kidney disease, are at higher risk of hypoglycemia.

    “People with type 1 diabetes, particularly those with concomitant chronic kidney disease, are at higher risk of hypoglycemia, which should be avoided by careful insulin and carbohydrate matching (129).”

    From The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) · cites this paper as [129]

    The Conventional Risk Factors section identifies reduced insulin clearance in renal failure as a hypoglycemia risk factor, and the Summary of Recommendations advises matching insulin action to glucose availability to avoid hypoglycemia. The paper does not extend the renal-failure finding to all chronic kidney disease, so the claim's broader CKD qualifier is not fully supported. No page numbers are available in our copy. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 68 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Cryer, P. E.
Affiliations
Barnes-Jewish Hospital (US)
Corresponding author
Cryer, Philip E.
Venue
Endocrinology and Metabolism Clinics of North America
Publisher
Elsevier BV
Published
2010-09
Volume
39
Issue
3
Pages
641-654
ISSN
0889-8529 (ISSN-L)
OpenAlex
W2009090185
Cited by
205
References
68
Citations by year
2026: 16 · 2025: 20 · 2024: 11 · 2023: 12 · 2022: 12 · 2021: 21 · 2020: 14 · 2019: 13 · 2018: 12 · 2017: 11 · 2016: 9 · 2015: 10 · 2014: 9 · 2013: 16 · 2012: 11
FWCI
1.50
Type
journal article
Language
en
Open access
Locations
  • Endocrinology and Metabolism Clinics of North America (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (5p60dk020579-35, UL1TR000448)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R37DK027085, P60-DK20579, R37-DK27085, T32 DK07120, P60-DK-020579, P30DK020579, T32DK007120)
  • National Center for Research Resources (UL1-RR-24992, M01-RR00036, UL1RR024992, M01RR000036)
  • NIH Clinical Center
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
hypoglycemia, type 1 diabetes, hypoglycemia-associated autonomic failure, iatrogenic hypoglycemia, hyperinsulinemia, insulin excess, hypoglycemia risk factors, insulin secretion
MeSH terms
Blood Glucose, Diabetes Mellitus, Type 1, Humans, Hypoglycemia, Models, Biological, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review